InfuSystem Holdings Free Cash Flow (FCF) History (INFU)
InfuSystem Holdings reported $23.8M in free cash flow for fiscal 2025, an increase of 23.14% from the previous fiscal year, with a free cash flow margin of 16.63%.
View full InfuSystem Holdings company overviewInfuSystem Holdings free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | $23.8M | $4.5M | +23.14% | +16.63% |
| 2024 | 2024-12-31 | $19.4M | $9.2M | +89.89% | +14.36% |
| 2023 | 2023-12-31 | $10.2M | −$6.3M | −38.32% | +8.11% |
| 2022 | 2022-12-31 | $16.5M | −$801,000 | −4.62% | +15.04% |
| 2021 | 2021-12-31 | $17.3M | −$1.9M | −9.64% | +16.93% |
| 2020 | 2020-12-31 | $19.2M | $8.2M | +75.23% | +19.70% |
| 2019 | 2019-12-31 | $10.9M | −$161,000 | −1.45% | +13.50% |
| 2018 | 2018-12-31 | $11.1M | $3.5M | +45.92% | +105.27% |
| 2017 | 2017-12-31 | $7.6M | −$127,000 | −1.64% | +76.20% |
| 2016 | 2016-12-31 | $7.7M | $1.0M | +14.85% | +10.98% |
| 2015 | 2015-12-31 | $6.7M | $1.5M | +28.14% | +9.55% |
| 2014 | 2014-12-31 | $5.3M | $2.5M | +91.97% | +7.91% |
| 2013 | 2013-12-31 | $2.7M | $3.8M | — | +4.40% |
| 2012 | 2012-12-31 | −$1.1M | $375,000 | — | −1.85% |
| 2011 | 2011-12-31 | −$1.5M | −$9.8M | — | −2.68% |
| 2010 | 2010-12-31 | $8.4M | $3.3M | +64.21% | +17.72% |
| 2009 | 2009-12-31 | $5.1M | — | — | +13.08% |
InfuSystem Holdings quarterly free cash flow
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $6.7M | −$106,000 | −1.56% | +18.10% |
| Q1 2026 | 2026-03-31 | $813,000 | −$836,000 | −50.70% | +2.41% |
| Q4 2025 | 2025-12-31 | $7.0M | −$408,000 | −5.51% | +19.30% |
| Q3 2025 | 2025-09-30 | $8.4M | −$1.4M | −14.13% | +23.06% |
| Q2 2025 | 2025-06-30 | $6.8M | $4.8M | +244.42% | +18.87% |
| Q1 2025 | 2025-03-31 | $1.6M | $1.5M | +745.64% | +4.75% |
| Q4 2024 | 2024-12-31 | $7.4M | $3.2M | +74.14% | +21.87% |
| Q3 2024 | 2024-09-30 | $9.8M | $5.7M | +136.58% | +27.74% |
| Q2 2024 | 2024-06-30 | $2.0M | −$303,000 | −13.32% | +5.85% |
| Q1 2024 | 2024-03-31 | $195,000 | $663,000 | — | +0.61% |
| Q4 2023 | 2023-12-31 | $4.3M | $95,000 | +2.29% | +13.38% |
| Q3 2023 | 2023-09-30 | $4.1M | $921,000 | +28.59% | +12.98% |
| Q2 2023 | 2023-06-30 | $2.3M | −$3.0M | −56.74% | +7.17% |
| Q1 2023 | 2023-03-31 | −$468,000 | −$4.4M | — | −1.54% |
| Q4 2022 | 2022-12-31 | $4.2M | $817,000 | +24.48% | +14.41% |
| Q3 2022 | 2022-09-30 | $3.2M | −$2.3M | −41.63% | +11.81% |
| Q2 2022 | 2022-06-30 | $5.3M | −$708,000 | −11.87% | +19.45% |
| Q1 2022 | 2022-03-31 | $3.9M | $1.4M | +55.19% | +14.57% |
| Q4 2021 | 2021-12-31 | $3.3M | −$4.0M | −54.79% | +12.59% |
| Q3 2021 | 2021-09-30 | $5.5M | −$2.7M | −32.88% | +20.77% |
| Q2 2021 | 2021-06-30 | $6.0M | $2.4M | +67.90% | +24.03% |
| Q1 2021 | 2021-03-31 | $2.5M | $2.5M | +8875.00% | +10.27% |
| Q4 2020 | 2020-12-31 | $7.4M | $9.1M | — | +29.88% |
| Q3 2020 | 2020-09-30 | $8.2M | $4.1M | +100.61% | +32.72% |
| Q2 2020 | 2020-06-30 | $3.6M | $4.9M | — | +13.67% |
| Q1 2020 | 2020-03-31 | $28,000 | $2.3M | — | +0.13% |
| Q4 2019 | 2019-12-31 | −$1.7M | −$684,000 | — | −8.03% |
| Q3 2019 | 2019-09-30 | $4.1M | $2.5M | +158.39% | +19.07% |
| Q2 2019 | 2019-06-30 | −$1.3M | −$3.5M | — | −6.63% |
| Q1 2019 | 2019-03-31 | −$2.3M | −$2.2M | — | −12.46% |
| Q4 2018 | 2018-12-31 | −$1.1M | −$1.9M | — | −32.84% |
| Q3 2018 | 2018-09-30 | $1.6M | −$349,000 | −18.04% | +54.61% |
| Q2 2018 | 2018-06-30 | $2.2M | $375,000 | +20.89% | +91.83% |
| Q1 2018 | 2018-03-31 | −$67,000 | $2.4M | — | −3.25% |
| Q4 2017 | 2017-12-31 | $891,000 | $3.5M | — | +29.35% |
| Q3 2017 | 2017-09-30 | $1.9M | $259,000 | +15.45% | +85.39% |
| Q2 2017 | 2017-06-30 | $1.8M | $4.2M | — | +82.60% |
| Q1 2017 | 2017-03-31 | −$2.5M | $480,000 | — | −97.62% |
| Q4 2016 | 2016-12-31 | −$2.7M | $4.8M | — | −15.75% |
| Q3 2016 | 2016-09-30 | $1.7M | $162,000 | +10.70% | +9.73% |
| Q2 2016 | 2016-06-30 | −$2.4M | −$1.8M | — | −13.14% |
| Q1 2016 | 2016-03-31 | −$2.9M | $2.1M | — | −16.05% |
| Q4 2015 | 2015-12-31 | −$7.4M | −$5.3M | — | −39.52% |
| Q3 2015 | 2015-09-30 | $1.5M | $1.8M | — | +8.27% |
| Q2 2015 | 2015-06-30 | −$625,000 | $330,000 | — | −3.69% |
| Q1 2015 | 2015-03-31 | −$5.1M | −$3.3M | — | −30.58% |
| Q4 2014 | 2014-12-31 | −$2.1M | −$3.5M | — | −13.05% |
| Q3 2014 | 2014-09-30 | −$246,000 | −$1.9M | — | −1.48% |
| Q2 2014 | 2014-06-30 | −$955,000 | −$769,000 | — | −5.83% |
| Q1 2014 | 2014-03-31 | −$1.8M | −$1.6M | — | −10.23% |
| Q4 2013 | 2013-12-31 | $1.4M | $4.0M | — | +7.98% |
| Q3 2013 | 2013-09-30 | $1.7M | −$512,000 | −23.15% | +10.80% |
| Q2 2013 | 2013-06-30 | −$186,000 | −$1.6M | — | −1.27% |
| Q1 2013 | 2013-03-31 | −$145,000 | $2.0M | — | −0.99% |
| Q4 2012 | 2012-12-31 | −$2.6M | −$745,000 | — | −16.09% |
| Q3 2012 | 2012-09-30 | $2.2M | $2.4M | — | +15.60% |
| Q2 2012 | 2012-06-30 | $1.4M | $670,000 | +89.21% | +10.10% |
| Q1 2012 | 2012-03-31 | −$2.1M | −$1.8M | — | −14.71% |
| Q4 2011 | 2011-12-31 | −$1.9M | — | — | −13.30% |
| Q3 2011 | 2011-09-30 | −$143,000 | −$3.5M | — | −0.99% |
| Q2 2011 | 2011-06-30 | $751,000 | — | — | +5.72% |
| Q1 2011 | 2011-03-31 | −$316,000 | — | — | −2.44% |
| Q3 2010 | 2010-09-30 | $3.4M | — | — | +26.33% |
InfuSystem Holdings free cash flow growth trends
Over the last five reported fiscal years, free cash flow grew from $19.2M to $23.8M, a compound annual growth rate of 4.45%. InfuSystem Holdings's latest reported quarter, Q2 2026, generated $6.7M in free cash flow, a decrease of 1.56% year over year.
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
How free cash flow is calculated
TickerStat calculates free cash flow as reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review InfuSystem Holdings source filings ↗